ScholarIQanswers from OpenAlex

High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial

PaperCitations, authors & open-access status

High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial have?

ScholarIQcitation count

High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial has 159 citations in the OpenAlex counts ScholarIQ stores.

When was High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial published?

ScholarIQyear

High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial has 2004 year in the ScholarIQ index.

What is the open-access status of High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial?

ScholarIQoa status

High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial has closed oa status in the ScholarIQ index.

What is the DOI of High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial?

ScholarIQdoi

The DOI for High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial is on the source record.

What is the PMID of High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial?

ScholarIQpmid

The PMID for High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial is on the source record.

What is the OpenAlex record for High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial?

ScholarIQopenalex

The OpenAlex for High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial